1919 Investment Counsel’s Core Laboratories CLB Stock Holding History

1919 Investment Counsel’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$3.94M	Sell	26,924 -625	-2%	-$96.5K	0.08%	216
2014 Q2	$4.6M	Sell	27,549 -1,050	-4%	-$187K	0.09%	203
2014 Q1	$5.68M	Sell	28,599 -451	-2%	-$85.1K	0.12%	159
2013 Q4	$5.55M	Sell	29,050 -475	-2%	-$88.4K	0.12%	163
2013 Q3	$5M	Sell	29,525 -585	-2%	-$90.8K	0.11%	167
2013 Q2	$4.57M	Buy	+30,110	New	+$4.27M	0.11%	172

Other funds holding CLB

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

1919 Investment Counsel's CLB Position: Q3 2014 in Review

1919 Investment Counsel reduced its Core Laboratories (CLB) stake by 2.3% in Q3 2014, selling an estimated $96.5K and leaving 26,924 shares worth $3.94M. The position accounts for 0.08% of the portfolio, ranked #216.

1919 Investment Counsel first reported a position in CLB in Q2 2013 and has held it in 6 quarters since. The position peaked at $5.68M in Q1 2014. 344 funds tracked by Wall St. Rank hold CLB as of Q3 2014.

1919 Investment Counsel held 26,924 shares of Core Laboratories worth $3.94M as of Q3 2014.
1919 Investment Counsel sold 625 Core Laboratories shares in Q3 2014, an estimated $96.5K.
Core Laboratories made up 0.08% of 1919 Investment Counsel's portfolio in Q3 2014, its #216 holding.
1919 Investment Counsel first reported a position in Core Laboratories in Q2 2013 and has held it in 6 quarters since.
1919 Investment Counsel's Core Laboratories position peaked at $5.68M in Q1 2014.
344 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.